The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2016

Filed:

Mar. 07, 2014
Applicant:

Masssachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

Steven A. Castleberry, Cambridge, MA (US);

Paula T. Hammond, Newton, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7105 (2006.01); A61K 9/70 (2006.01); A61K 45/06 (2006.01); A61L 27/12 (2006.01); A61L 27/22 (2006.01); A61L 27/46 (2006.01); A61L 31/02 (2006.01); A61L 31/04 (2006.01); A61L 31/12 (2006.01); A61L 31/16 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 31/7105 (2013.01); A61L 27/12 (2013.01); A61L 27/22 (2013.01); A61L 27/46 (2013.01); A61L 31/026 (2013.01); A61L 31/047 (2013.01); A61L 31/127 (2013.01); A61L 31/16 (2013.01); A61L 2400/12 (2013.01); A61L 2420/08 (2013.01);
Abstract

The present invention provides, among other things, multilayer film coating compositions, coated substrates and methods thereof. In some embodiments, a structure includes a substrate; and a multilayer film coated on the substrate, wherein adjacent layers of the multilayer film are associated with one another via one or more non-covalent interactions, wherein the multilayer film comprises a first nucleic acid agent present at a loading density, and further wherein the multilayer film is characterized in that, when the structure is placed on a subject so that the multilayer film contacts cells, the first nucleic acid agent is released with a profile characterized by a feature selected from the group consisting of 1) being a burst-free release; 2) being a sustained release; and 3) exhibiting in vitro and/or in vivo biological effectiveness.


Find Patent Forward Citations

Loading…